254 filings
Page 4 of 13
S-8
au5yu6s26b2ut nf4i
1 Mar 22
Registration of securities for employees
4:50pm
8-K
6fy340v
1 Mar 22
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm
8-K
3w16ds r0mil
10 Jan 22
Results of Operations and Financial Condition
7:00am
8-K
aiax 0n33
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
mprn8g0fa7wire48u59n
20 Dec 21
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
7:00am
8-K
tnads
8 Nov 21
Cara Therapeutics Reports Third Quarter 2021 Financial Results
4:10pm
8-K
gsgh fvlv7a7kdi59mw4
3 Nov 21
Cara Therapeutics Announces CEO Transition
8:10am
8-K
e9z1w
31 Aug 21
Other Events
12:00am
8-K
za1n7ie8rf8fqcg
23 Aug 21
Other Events
4:44pm
8-K
hzgcqh8gvq zd
12 Aug 21
Regulation FD Disclosure
8:03am
8-K
dh9fpwto5ba lo
9 Aug 21
Cara Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
udtor6
4 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
vhq uuvwm6
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
5amqq4wg n0iocd
10 May 21
Cara Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
8-K
cflqb
29 Apr 21
Cara Therapeutics Announces Topline Results From
7:21am